1 study found for:    NCT01704755
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis
Interventions: Drug: ABT-450/r/ABT-267, ABT-333;   Drug: Ribavirin (RBV)

Indicates status has not been verified in more than two years